 Immunotherapy is effective for cutaneous, mucosal, uveal and conjunctival melanoma, but the variable efficacy can be explained by the different biological features of each type. The review of the main results obtained with immune checkpoint inhibitors in various types of melanoma was conducted. This article was authored by Ernesto Rossi, Giovanni Scanzari, Brigida Anna Maiorano, and others.